Developer of a medical product designed to treat Molluscum disease. The company's product is based in a blend of phytochemical and antiviral compounds found in nature which helps to remove lesions and pain from the disease easily, enabling users to get relief from this disease within one to two weeks.
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
1. Accelerator/Incubator | Completed | Startup |
Name | Title | Board Seat | Contact Info |
---|---|---|---|
James Ragsdale | Chief Executive Officer | ||
Sass Robert | Chief Financial Officer | ||
Paul Konz | Chief Operating Officer |
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
University of Central Florida Business Incubator | Accelerator/Incubator | Minority | 000 0000 | 000000 0 |